165 related articles for article (PubMed ID: 17452529)
1. Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway.
Cude K; Wang Y; Choi HJ; Hsuan SL; Zhang H; Wang CY; Xia Z
J Cell Biol; 2007 Apr; 177(2):253-64. PubMed ID: 17452529
[TBL] [Abstract][Full Text] [Related]
2. Alternative ERK5 regulation by phosphorylation during the cell cycle.
Iñesta-Vaquera FA; Campbell DG; Tournier C; Gómez N; Lizcano JM; Cuenda A
Cell Signal; 2010 Dec; 22(12):1829-37. PubMed ID: 20667468
[TBL] [Abstract][Full Text] [Related]
3. The ERK-RSK1 activation by growth factors at G2 phase delays cell cycle progression and reduces mitotic aberrations.
Nam HJ; Kim S; Lee MW; Lee BS; Hara T; Saya H; Cho H; Lee JH
Cell Signal; 2008 Jul; 20(7):1349-58. PubMed ID: 18450423
[TBL] [Abstract][Full Text] [Related]
4. Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.
Simões AE; Pereira DM; Gomes SE; Brito H; Carvalho T; French A; Castro RE; Steer CJ; Thibodeau SN; Rodrigues CM; Borralho PM
Cell Death Dis; 2015 Apr; 6(4):e1718. PubMed ID: 25855966
[TBL] [Abstract][Full Text] [Related]
5. Multisite phosphorylation of Erk5 in mitosis.
Díaz-Rodríguez E; Pandiella A
J Cell Sci; 2010 Sep; 123(Pt 18):3146-56. PubMed ID: 20736311
[TBL] [Abstract][Full Text] [Related]
6. The MAP kinase ERK5 binds to and phosphorylates p90 RSK.
Ranganathan A; Pearson GW; Chrestensen CA; Sturgill TW; Cobb MH
Arch Biochem Biophys; 2006 May; 449(1-2):8-16. PubMed ID: 16626623
[TBL] [Abstract][Full Text] [Related]
7. Truncated MEK1 is required for transient activation of MAPK signalling in G2 phase cells.
Pike T; Widberg C; Goodall A; Payne E; Giles N; Hancock J; Gabrielli B
Cell Signal; 2013 Jun; 25(6):1423-8. PubMed ID: 23524336
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle.
Hu Q; Lu JF; Luo R; Sen S; Maity SN
Nucleic Acids Res; 2006; 34(21):6272-85. PubMed ID: 17098936
[TBL] [Abstract][Full Text] [Related]
9. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.
Squires MS; Nixon PM; Cook SJ
Biochem J; 2002 Sep; 366(Pt 2):673-80. PubMed ID: 12069688
[TBL] [Abstract][Full Text] [Related]
10. ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry.
Zen K; Yasui K; Nakajima T; Zen Y; Zen K; Gen Y; Mitsuyoshi H; Minami M; Mitsufuji S; Tanaka S; Itoh Y; Nakanuma Y; Taniwaki M; Arii S; Okanoue T; Yoshikawa T
Genes Chromosomes Cancer; 2009 Feb; 48(2):109-20. PubMed ID: 18973138
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB pathway is involved in griseofulvin-induced G2/M arrest and apoptosis in HL-60 cells.
Uen YH; Liu DZ; Weng MS; Ho YS; Lin SY
J Cell Biochem; 2007 Aug; 101(5):1165-75. PubMed ID: 17226769
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the G2/M transition by p53.
Taylor WR; Stark GR
Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
[TBL] [Abstract][Full Text] [Related]
13. Erk5 is activated and acts as a survival factor in mitosis.
Gírio A; Montero JC; Pandiella A; Chatterjee S
Cell Signal; 2007 Sep; 19(9):1964-72. PubMed ID: 17624732
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle-dependent expression of cIAP2 at G2/M phase contributes to survival during mitotic cell cycle arrest.
Jin HS; Lee TH
Biochem J; 2006 Oct; 399(2):335-42. PubMed ID: 16813569
[TBL] [Abstract][Full Text] [Related]
15. Knock-down of CIAPIN1 sensitizes K562 chronic myeloid leukemia cells to Imatinib by regulation of cell cycle and apoptosis-associated members via NF-κB and ERK5 signaling pathway.
Wang J; Li Q; Wang C; Xiong Q; Lin Y; Sun Q; Jin H; Yang F; Ren X; Pang T
Biochem Pharmacol; 2016 Jan; 99():132-45. PubMed ID: 26679828
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase.
Kruyt FA; Dijkmans LM; Arwert F; Joenje H
Cancer Res; 1997 Jun; 57(11):2244-51. PubMed ID: 9187128
[TBL] [Abstract][Full Text] [Related]
18. Enhanced G2-M arrest by nuclear factor-{kappa}B-dependent p21waf1/cip1 induction.
Wuerzberger-Davis SM; Chang PY; Berchtold C; Miyamoto S
Mol Cancer Res; 2005 Jun; 3(6):345-53. PubMed ID: 15972853
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
[TBL] [Abstract][Full Text] [Related]
20. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
